Interview with Loretto Callaghan, CPO Head, Novartis Ireland
Ms. Callaghan, you have been in your current position as CPO Head for Novartis Ireland for about 6 years. How have you seen the organization evolve over this period? The…
Address: Novo Nordisk Ireland, 2nd Floor, 2 Hume St. Dublin 2,Ireland
Tel: 1850 665665
Web: http://www.novonordisk.ie/documents/home_page/document/index.asp
General information:
Irish office: 3/4 Upper Pembroke Street, Dublin 2
Global headquarters: Bagsværd, Denmark
Irish workforce: 24 employees
Global workforce: More than 31,300 employees
International production facilities in seven countries
Product areas
Diabetes care
Hormone replacement therapy (HRT)
Haemostasis management
Growth hormone therapy.
Clinical research:
Before any medicine is available for doctors to prescribe, it must be granted a license by the government. Therefore, all medicines have to be tested in appropriate patients to ensure that they reach the standards of safety and efficacy required by governmental agencies around the world. This is achieved by conducting clinical trials in which patients freely volunteer to try new medicines so that relevant data can be obtained. All clinical trials must conform to globally accepted scientific and ethical standards before they can proceed.
Novo Nordisk is committed to ensuring that all its products meet the highest quality standards and are rigorously tested by performing clinical trials in collaboration with doctors and nurses around the world, including sites in Ireland.
Novo Nordisk way:
In 1923, our Danish founders began a journey to change diabetes.
Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes.
Our ambition is to strengthen our leadership in diabetes. Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world. We aspire to change possibilities in haemophilia and other serious chronic conditions where we can make a difference. Growing our business and delivering competitive financial results is what allows us to help patients live better lives, offer an attractive return to our shareholders and contribute to our communities.
We never compromise on quality and business ethics
Our business philosophy is one of balancing financial, social and environmental considerations – we call it ‘The Triple Bottom Line’
We are open and honest, ambitious and accountable, and treat everyone with respect
We offer opportunities for our people to realise their potential.
Every day, we must make difficult choices, always keeping in mind, what is best for patients, our employees and our shareholders in the long run.
It’s the Novo Nordisk Way.
Haemophilia and Eating Disorders.
Diabetes Care.
Hormone Replacement Therapy.
Ms. Callaghan, you have been in your current position as CPO Head for Novartis Ireland for about 6 years. How have you seen the organization evolve over this period? The…
Ms. Kelly, you have been General Manager of this affiliate since the creation of Astellas in 2005, and have overseen, since 2006, the local implementation of Astellas’ VISION 2015. How…
Dr. Edwards, you have been both a lecturer and a researcher. What made you ‘come over to the dark side’ and become a manager? I do not find it to…
Lilly has invested over one billion EUR in its Kinsale site to date—including a recent 330 million EUR expansion that positions Ireland as a key location for Lilly’s biotech pipeline.…
The Irish pharmaceutical industry employs more than 50,000 people, and generates more than 50% of Irish exports. How would the Minister sum the importance of this sector to the Irish…
In 2010, you gave a lecture for the Great Place to Work Institute, and spoke about how you have navigated the change and rapid growth MSD Ireland has experienced in…
Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in pharmacology. I have worked…
You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market have principally occurred in the…
Celgene just announced very impressive second quarter results for its global operations, with a 38% increase in revenue partly led by strong growth in Europe. Within the global performance of…
See our Cookie Privacy Policy Here